Avita Medical Inc (AU:AVH) — Market Cap & Net Worth
Market Cap & Net Worth: Avita Medical Inc (AVH)
Avita Medical Inc (AU:AVH) has a market capitalization of $188.51 Million (AU$266.42 Million) as of September 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #16861 globally and #484 in its home market, demonstrating a 9.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avita Medical Inc's stock price AU$3.05 by its total outstanding shares 153883445 (153.88 Million). Also see Avita Medical Inc assets under control for a full breakdown of the balance sheet.
Avita Medical Inc Market Cap History: 2015 to 2026
Avita Medical Inc's market capitalization history from 2015 to 2026. Data shows growth from $178.73 Million to $332.09 Million (3.39% CAGR). Also see AVH cash flow conversion for how efficiently the company converts equity into cash flow.
Avita Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avita Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Avita Medical Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.78x
Avita Medical Inc's market cap is 1.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $233.27 Million | $1.00 Million | -$10.27 Million | 232.80x | N/A |
| 2017 | $137.19 Million | $1.18 Million | -$11.51 Million | 116.20x | N/A |
| 2018 | $176.39 Million | $1.26 Million | -$17.21 Million | 140.53x | N/A |
| 2019 | $1.40 Billion | $5.40 Million | -$24.62 Million | 260.28x | N/A |
| 2020 | $537.88 Million | $20.67 Million | -$60.90 Million | 26.03x | N/A |
| 2021 | $372.38 Million | $14.26 Million | -$42.03 Million | 26.11x | N/A |
| 2022 | $213.41 Million | $45.45 Million | -$34.60 Million | 4.70x | N/A |
| 2023 | $467.11 Million | $50.56 Million | -$39.17 Million | 9.24x | N/A |
| 2024 | $462.75 Million | $50.14 Million | -$35.38 Million | 9.23x | N/A |
| 2025 | $114.33 Million | $64.25 Million | -$61.84 Million | 1.78x | N/A |
Competitor Companies of AVH by Market Capitalization
Companies near Avita Medical Inc in the global market cap rankings as of September 19, 2026. Review Avita Medical Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Avita Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Avita Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Avita Medical Inc's market cap moved from $178.73 Million to $ 332.09 Million, with a yearly change of 3.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$332.09 Million | +190.48% |
| 2025 | AU$114.33 Million | -75.29% |
| 2024 | AU$462.75 Million | -0.93% |
| 2023 | AU$467.11 Million | +118.88% |
| 2022 | AU$213.41 Million | -42.69% |
| 2021 | AU$372.38 Million | -30.77% |
| 2020 | AU$537.88 Million | -61.71% |
| 2019 | AU$1.40 Billion | +696.30% |
| 2018 | AU$176.39 Million | +28.57% |
| 2017 | AU$137.19 Million | -41.19% |
| 2016 | AU$233.27 Million | +30.51% |
| 2015 | AU$178.73 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Avita Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $188.51 Million USD |
| MoneyControl | $188.51 Million USD |
| MarketWatch | $188.51 Million USD |
| marketcap.company | $188.51 Million USD |
| Reuters | $188.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more